Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib Dose Escalation in Metastatic RCC
NCT00557830Phase 2Terminated
- Sponsor
- Accelerated Community Oncology Research Network
- Start
- Jan 2008
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Accelerated Community Oncology Research Network. Started Jan 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00557830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557830.